155 related articles for article (PubMed ID: 29660369)
1. Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men.
Waterhouse RL; Van Neste L; Moses KA; Barnswell C; Silberstein JL; Jalkut M; Tutrone R; Sylora J; Anglade R; Murdock M; Shiffman Z; Vandenberg T; Shah N; Carter M; Krispin M; Groskopf J; Van Criekinge W
Urology; 2019 Jun; 128():62-65. PubMed ID: 29660369
[TBL] [Abstract][Full Text] [Related]
2. The impact of African American race on prostate cancer detection on repeat prostate biopsy in a veteran population.
Sterling WA; Weiner J; Schreiber D; Mehta K; Weiss JP
Int Urol Nephrol; 2016 Dec; 48(12):2015-2021. PubMed ID: 27580731
[TBL] [Abstract][Full Text] [Related]
3. The significance of anterior prostate lesions on multiparametric magnetic resonance imaging in African-American men.
Kongnyuy M; Sidana A; George AK; Muthigi A; Iyer A; Fascelli M; Kadakia M; Frye TP; Ho R; Mertan F; Minhaj Siddiqui M; Su D; Merino MJ; Turkbey B; Choyke PL; Wood BJ; Pinto PA
Urol Oncol; 2016 Jun; 34(6):254.e15-21. PubMed ID: 26905304
[TBL] [Abstract][Full Text] [Related]
4. Reduced Rate of Repeated Prostate Biopsies Observed in ConfirmMDx Clinical Utility Field Study.
Wojno KJ; Costa FJ; Cornell RJ; Small JD; Pasin E; Van Criekinge W; Bigley JW; Van Neste L
Am Health Drug Benefits; 2014 May; 7(3):129-34. PubMed ID: 24991397
[TBL] [Abstract][Full Text] [Related]
5. Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies.
Van Neste L; Partin AW; Stewart GD; Epstein JI; Harrison DJ; Van Criekinge W
Prostate; 2016 Sep; 76(12):1078-87. PubMed ID: 27121847
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic risk score improves prostate cancer risk assessment.
Van Neste L; Groskopf J; Grizzle WE; Adams GW; DeGuenther MS; Kolettis PN; Bryant JE; Kearney GP; Kearney MC; Van Criekinge W; Gaston SM
Prostate; 2017 Sep; 77(12):1259-1264. PubMed ID: 28762545
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies.
Trock BJ; Brotzman MJ; Mangold LA; Bigley JW; Epstein JI; McLeod D; Klein EA; Jones JS; Wang S; McAskill T; Mehrotra J; Raghavan B; Partin AW
BJU Int; 2012 Jul; 110(1):56-62. PubMed ID: 22077694
[TBL] [Abstract][Full Text] [Related]
8. Racial Variation in the Outcome of Subsequent Prostate Biopsies in Men With an Initial Diagnosis of Atypical Small Acinar Proliferation.
Scott Libby R; Kramer JJ; Tue Nguyen HM; Feibus A; Thomas R; Silberstein JL
Clin Genitourin Cancer; 2017 Dec; 15(6):e995-e999. PubMed ID: 28566201
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
[TBL] [Abstract][Full Text] [Related]
10. The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy.
Cash H; Maxeiner A; Stephan C; Fischer T; Durmus T; Holzmann J; Asbach P; Haas M; Hinz S; Neymeyer J; Miller K; Günzel K; Kempkensteffen C
World J Urol; 2016 Apr; 34(4):525-32. PubMed ID: 26293117
[TBL] [Abstract][Full Text] [Related]
11. Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.
Partin AW; Van Neste L; Klein EA; Marks LS; Gee JR; Troyer DA; Rieger-Christ K; Jones JS; Magi-Galluzzi C; Mangold LA; Trock BJ; Lance RS; Bigley JW; Van Criekinge W; Epstein JI
J Urol; 2014 Oct; 192(4):1081-7. PubMed ID: 24747657
[TBL] [Abstract][Full Text] [Related]
12. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers.
Hoeks CM; Schouten MG; Bomers JG; Hoogendoorn SP; Hulsbergen-van de Kaa CA; Hambrock T; Vergunst H; Sedelaar JP; Fütterer JJ; Barentsz JO
Eur Urol; 2012 Nov; 62(5):902-9. PubMed ID: 22325447
[TBL] [Abstract][Full Text] [Related]
13. Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy Strategies.
Mendhiratta N; Meng X; Rosenkrantz AB; Wysock JS; Fenstermaker M; Huang R; Deng FM; Melamed J; Zhou M; Huang WC; Lepor H; Taneja SS
Urology; 2015 Dec; 86(6):1192-8. PubMed ID: 26335497
[TBL] [Abstract][Full Text] [Related]
14. A Prospective Comparison of Selective Multiparametric Magnetic Resonance Imaging Fusion-Targeted and Systematic Transrectal Ultrasound-Guided Biopsies for Detecting Prostate Cancer in Men Undergoing Repeated Biopsies.
Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
Urol Int; 2017; 99(4):384-391. PubMed ID: 28651247
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic differences between prostate cancers detected during initial and repeat transrectal ultrasound-guided biopsy in Korea.
Park DJ; Kim KH; Kwon TG; Kim CI; Park CH; Park JS; Kim DY; Kim JS; Moon KH; Lee KS
Korean J Urol; 2014 Nov; 55(11):718-24. PubMed ID: 25405013
[TBL] [Abstract][Full Text] [Related]
16. Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate Biopsies.
Maxeiner A; Nest AM; Stephan C; Cash H; Baur ADJ; Fischer T; Kilic E; Piper SK; Nowak CP; Busch J; Miller K; Mang J
Urol Int; 2020; 104(3-4):205-213. PubMed ID: 31801153
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
[TBL] [Abstract][Full Text] [Related]
19. Detection of prostate cancer using magnetic resonance imaging/ultrasonography image-fusion targeted biopsy in African-American men.
Shin T; Smyth TB; Ukimura O; Ahmadi N; de Castro Abreu AL; Oishi M; Mimata H; Gill IS
BJU Int; 2017 Aug; 120(2):233-238. PubMed ID: 28111879
[TBL] [Abstract][Full Text] [Related]
20. Genetic ancestry and prostate cancer susceptibility SNPs in Puerto Rican and African American men.
Irizarry-Ramírez M; Kittles RA; Wang X; Salgado-Montilla J; Nogueras-González GM; Sánchez-Ortiz R; Guerrios L; Rivera K; Shah E; Prokhorova I; Roberson P; Troncoso P; Pettaway CA
Prostate; 2017 Jul; 77(10):1118-1127. PubMed ID: 28543179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]